‘Revolutionary’ lung cancer drug made available on NHS in England
The Guardian says Lung cancer patients in England will become the first in Europe to benefit from a “revolutionary” new drug that can halt the growth of tumours by targeting the so-called “Death Star” mutation.
The medication, Sotorasib, will be fast-tracked to NHS patients after it was proven in clinical trials to stop lung cancer growing for seven months.
The drug targets the mutation on the KRAS gene, which is found in a quarter of all tumours and is known as the “Death Star” mutation because of its spherical appearance and impenetrable nature.
FOLLOW US ON SOCIAL MEDIA AND SHARE WTX NEWS WITH YOUR FRIENDS AND FAMILY:
Facebook – Please like our page
Twitter – Twitter updates available in English and Arabic. Please follow us and we would love to hear from you
Instagram – Follow our pages in English and ArabicLeave a comment